Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral Nerve Sheath Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Not applicableLooking for participantsNCT05008185
What this trial is testing

Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation

Who this might be right for
Neuroma
Medstar Health Research Institute 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT01089101
What this trial is testing

Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

Who this might be right for
Low Grade GliomaRecurrent Childhood Pilocytic AstrocytomaRecurrent Neurofibromatosis Type 1+3 more
National Cancer Institute (NCI) 217
Not applicableActive Not RecruitingNCT03820778
What this trial is testing

Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1

Who this might be right for
Neurofibromatosis 1NeurofibromaAtypical Neurofibroma+3 more
Children's National Research Institute 10
Early research (Phase 1)Study completedNCT00053937
What this trial is testing

Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00091351
What this trial is testing

Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis

Who this might be right for
Sarcoma
Alliance for Clinical Trials in Oncology 370
Not applicableUnknownNCT04004377
What this trial is testing

Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised

Who this might be right for
Acoustic Neuroma
University Hospital, Bordeaux 200
Testing effectiveness (Phase 2)Study completedNCT03719430
What this trial is testing

APX005M and Doxorubicin in Advanced Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Alexander Z. Wei, MD 27
Not applicableTemporarily pausedNCT06934928
What this trial is testing

Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)

Who this might be right for
Neurofibromatosis 1 (NF1)Neurofibromatosis Type I
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02839720
What this trial is testing

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

Who this might be right for
Cutaneous NeurofibromaNeurofibromatosis Type 1Optic Nerve Glioma
National Cancer Institute (NCI) 11
Early research (Phase 1)Active Not RecruitingNCT04590235
What this trial is testing

Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)

Who this might be right for
Neurofibromatosis 1Neurofibroma Plexiform
AstraZeneca 32
Not applicableStudy completedNCT00340522
What this trial is testing

Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development

Who this might be right for
Cancer
National Cancer Institute (NCI) 20
Post-approval studies (Phase 4)WithdrawnNCT02415257
What this trial is testing

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Who this might be right for
Vestibular Schwannoma
Lund University
Not applicableUnknownNCT03518710
What this trial is testing

Vision, Attention and Reading in Neurofibromatosis Type 1 (NF1) Children

Who this might be right for
Neurofibromatosis Type 1
University Hospital, Toulouse 15
Not applicableUnknownNCT03981510
What this trial is testing

Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation

Who this might be right for
ConstipationChildhood Acute Lymphoblastic LeukemiaNeurofibromatosis 1+1 more
University of Aarhus 80
Early research (Phase 1)Study completedNCT00931931
What this trial is testing

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors

Who this might be right for
RhabdomyosarcomaOsteosarcomaEwing Sarcoma+6 more
Timothy Cripe 18
Testing effectiveness (Phase 2)WithdrawnNCT03109301
What this trial is testing

Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Neoplasms, Nerve TissueNeurofibromatosis 1Heredodegenerative Disorders, Nervous System+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00450736
What this trial is testing

Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
University of Miami 3
Not applicableStudy completedNCT02963896
What this trial is testing

Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma

Who this might be right for
Vestibular Schwannoma
University Hospital, Motol 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07707947
What this trial is testing

Selumetinib for NF2-Related Schwannomatosis

Who this might be right for
Neurofibromatosis Type 2NF2NF2-related Schwannomatosis+3 more
Beijing Tiantan Hospital 20
Next Page